Clinical Trial Update: A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)

View source ↗

Summary

A multi-center observational registry of subjects with secondary hyperparathyroidism and chronic kidney disease, completed to collect real-world data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Snippet

Sponsor: Amgen | Conditions: Nephrology | Status: COMPLETED